BFI CO., LLC sold 50.0% of their position (30K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.50M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/23/2018ACC: 0001144204-18-046141
-30K
Net shares
Net seller
$1.50M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions4
Class A Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
100.0%
8/21/2018
30K→60K
Class A Common Stock
Direct
Shares
−10K
Price / share
$50.35
Trade value
$503.50K
% of position
16.7%
8/21/2018
60K→50K
Class A Common Stock
Direct
Shares
−10K
Price / share
$49.92
Trade value
$499.20K
% of position
20.0%
8/22/2018
50K→40K
Class A Common Stock
Direct
Shares
−10K
Price / share
$49.84
Trade value
$498.40K
% of position
25.0%
8/23/2018
40K→30K
Total
Net shares
+0.00
Net value
-$1.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/21/2018 | C · Conversion | +30K | — | — | 100.0% | 30K | 60K |
| Class A Common Stock Direct | 8/21/2018 | S · Sale | −10K | $50.35 | $503.50K | 16.7% | 60K | 50K |
| Class A Common Stock Direct | 8/22/2018 | S · Sale | −10K | $49.92 | $499.20K | 20.0% | 50K | 40K |
| Class A Common Stock Direct | 8/23/2018 | S · Sale | −10K | $49.84 | $498.40K | 25.0% | 40K | 30K |
| Total | +0.00 | -$1.50M | ||||||
Derivative Transactions1
Class B Common Stock
Direct
Converts to
Class A Common Stock
30K shares
Shares
−30K
Strike price
0
Held after
20.22M
Exercisable
—
8/21/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Direct | Class A Common Stock30K shares | 8/21/2018 | C · Conversion | −30K | 0 | — | 20.22M |